EGFR and non-small cell lung carcinoma: We therefore conclude that our mechanistical PBPK model accurately predicts image quality for EGFR expressing NSCLC tumors, while further study of distribution for drugs into tissues with high drug transporter abundancy and the effect of EGFR mutation on drug penetration is needed.